Literature DB >> 14519942

Influence of histamine in a liver injury model induced by Propionibacterium acnes and lipopolysaccharide.

Hiroshi Kurihara1, Harukazu Fukami, Sumio Asami, Hiroshi Shibata, Yoshinobu Kiso, Takaharu Tanaka, Xin-Sheng Yao.   

Abstract

In normal mice, plasma histamine levels were 29.4+/-10.1 pmol/ml. When 0.1 microg of lipopolysaccharide (LPS) was intravenously injected into Propionibacterium acnes (P. acnes)-primed ICR mice, histamine levels increased remarkably to 61.2+/-15.9 pmol/ml (p<0.001). An increase was also observed in liver tissues. Oral administration of histidine at 200 mg/kg once daily for 5 d before intravenous LPS injection increased the plasma alanine aminotransferase (ALT) activity to 2936.5+/-356.3 IU/l, a significant change compared with the controls (2244.8+/-425.5 IU/l, p<0.05). The 24 h survival rate after LPS injection was 72.7% in the mice treated with 50 mg/kg of ranitidine, in contrast with 50% in the control group although the treatment did not significantly decrease the plasma ALT activity. On the other hand, 50 mg/kg of pyrilamine significantly reduced plasma ALT activity (p<0.001). The results suggested that histamine levels are related to hepatic damage in the P. acnes plus LPS induction of liver injury.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14519942     DOI: 10.1248/bpb.26.1393

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  2 in total

1.  Production of trans-10, cis-12 conjugated linoleic acid in rice.

Authors:  Junko Kohno-Murase; Mari Iwabuchi; Saori Endo-Kasahara; Koichi Sugita; Hiroyasu Ebinuma; Jun Imamura
Journal:  Transgenic Res       Date:  2006-02       Impact factor: 2.788

2.  Anti-inflammatory effects of a polyphenols-rich extract from tea (Camellia sinensis) flowers in acute and chronic mice models.

Authors:  Bang-Tian Chen; Wei-Xi Li; Rong-Rong He; Yi-Fang Li; Bun Tsoi; Yu-Jia Zhai; Hiroshi Kurihara
Journal:  Oxid Med Cell Longev       Date:  2012-07-30       Impact factor: 6.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.